Computational Toxicity Prediction Using Chemical Structure and Gene Targets

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The rate of drug attrition due to clinical trial failures has increased, particularly due to safety reasons, as it is challenging to identify chemicals with unfavorable toxicity properties before conducting clinical trials.

Innovation Solution

A data-driven system that integrates chemical structure and gene target properties to generate a toxicity predictor score using a machine learning classifier, trained with reference chemicals that have passed or failed clinical trials, to predict the likelihood of toxicity and aid in designing therapeutic agents with reduced toxicity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional drug development methods are used, then the drug development process can be completed, but the rate of clinical trial failures due to toxicity increases

Engineering Contradiction:
Improveclinical trial success rateVSAvoiddrug toxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The system performs preliminary toxicity assessment by integrating chemical structure analysis with gene target prediction before clinical trials. The machine learning classifier evaluates multiple molecular descriptors and target vectors in advance to predict adverse effects, allowing problematic compounds to be identified and modified before expensive clinical testing begins.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system introduces gene target prediction as an intermediary step between chemical structure and toxicity assessment. By predicting the molecular targets of a compound and analyzing their association with adverse effects, the system creates a mechanistic bridge that improves the accuracy of toxicity predictions beyond simple structural similarity methods.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If comprehensive toxicity testing is conducted before clinical trials, then the accuracy of toxicity predictions improves, but the time and resources required increase

Engineering Contradiction:
Improvetoxicity prediction accuracyVSAvoiddrug development time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The system replaces extensive in vivo and in vitro toxicity testing with a computational machine learning model. The classifier uses molecular descriptors and gene target associations to predict toxicity outcomes, providing high-accuracy assessments without the time and resource requirements of traditional preclinical testing sequences.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system transforms the toxicity assessment problem from direct experimental measurement to computational parameter analysis. By evaluating multiple molecular descriptors (structural, physicochemical, pharmacokinetic) and their relationships with gene targets, the system achieves comprehensive toxicity evaluation through parameter integration rather than sequential testing.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If multiple molecular descriptors are integrated in the machine learning classifier, then the prediction accuracy increases, but the computational complexity increases

Engineering Contradiction:
Improvetoxicity prediction accuracyVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system segments the toxicity prediction task into distinct computational modules: chemical structure processing, molecular descriptor calculation, gene target prediction, and classification. Each module handles specific aspects of the analysis independently, making the overall complex system manageable and interpretable while maintaining high predictive accuracy.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The machine learning classifier is designed as a universal platform that integrates multiple types of molecular descriptors and gene target data through a unified framework. The same classifier architecture can process different compound types and predict various toxicity outcomes, reducing overall system complexity despite handling diverse inputs.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS11955208B2Computational systems and methods for improving the accuracy of drug toxicity predictions
Publication Date: 2024.04.09 CORNELL UNIVERSITY
  • US11955208B2 patent drawing
  • US11955208B2 patent drawing
  • US11955208B2 patent drawing

AI summary

In some implementations, the present solution can determine a first structural vector of a first chemical based on a chemical structure of the first chemical. The system can also determine first target vector of the first chemical based on at least one gene target for the first chemical. The system can use the structural vector and the target vector to generate a toxicity predictor score for the first chemical.